In vitro results with minimal blood toxicity of a combretastatin A4 analogue.
Chagas C, Mansano JV, da Silva EB, Petri G, da Costa Aguiar Alves Reis B, Schumacher ML, Haddad PS, Pereira EC, Britos TN, Barreiro EJ, Lima LM, Ferreira FF, Fonseca FLA.
Chagas C, et al. Among authors: da silva eb.
Invest New Drugs. 2024 Jun;42(3):318-325. doi: 10.1007/s10637-024-01440-4. Epub 2024 May 17.
Invest New Drugs. 2024.
PMID: 38758478